Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loutan

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Advances in Therapy|June 6, 1997
Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccineR Dumas, R Forrat, J Lang, et al.
Revue Medicale Suisse|June 20, 2008
[Security and travel]L Loutan, L Paredes, Y Jackson, et al.
Schweizerische Medizinische Wochenschrift|September 17, 1977
[Hypoglycemic sulfonylurea metabolites: clinical interest. Experiences with glibenclamide in the rat]H Samimi, L Loutan, L Balant, et al.
Schweizerische Medizinische Wochenschrift|November 11, 1978
[Metabolites of hypoglycemic sulfonylureas in kidney failure. Experience with glibenclamide]L Loutan, H Samimi, L Balant, et al.
Annales De Chirurgie Plastique Et Esthetique|April 3, 1999
[Falciform anemia and Plasmodium falciparum malaria: a threat to flap survival?]S Mariéthoz, B Pittet, L Loutan, et al.
Revue Medicale Suisse|June 6, 2012
[Rickettsial diseases in Switzerland, update for the general practitioner]G Eperon, O Péter, C Socolovschi, et al.
Revue Medicale Suisse|June 14, 2006
[Imported malaria in Geneva: 1998-2004]L Bochatay, P Sudre, F Chappuis, et al.
Journal of Travel Medicine|November 27, 1999
Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccinesP A Bovier, B Althaus, R Glueck, et al.
Revue Medicale Suisse|June 16, 2010
[Japanese encephalitis: risk for endemic populations and for travellers]C Hatz, S Inoubli, L Loutan, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 17, 2004
Sodium stibogluconate cardiotoxicity and safety of genericsS Rijal, F Chappuis, R Singh, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Advances in Therapy|June 6, 1997
Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccineR Dumas, R Forrat, J Lang, et al.
Revue Medicale Suisse|June 20, 2008
[Security and travel]L Loutan, L Paredes, Y Jackson, et al.
Schweizerische Medizinische Wochenschrift|September 17, 1977
[Hypoglycemic sulfonylurea metabolites: clinical interest. Experiences with glibenclamide in the rat]H Samimi, L Loutan, L Balant, et al.
Schweizerische Medizinische Wochenschrift|November 11, 1978
[Metabolites of hypoglycemic sulfonylureas in kidney failure. Experience with glibenclamide]L Loutan, H Samimi, L Balant, et al.
Annales De Chirurgie Plastique Et Esthetique|April 3, 1999
[Falciform anemia and Plasmodium falciparum malaria: a threat to flap survival?]S Mariéthoz, B Pittet, L Loutan, et al.
Revue Medicale Suisse|June 6, 2012
[Rickettsial diseases in Switzerland, update for the general practitioner]G Eperon, O Péter, C Socolovschi, et al.
Revue Medicale Suisse|June 14, 2006
[Imported malaria in Geneva: 1998-2004]L Bochatay, P Sudre, F Chappuis, et al.
Journal of Travel Medicine|November 27, 1999
Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccinesP A Bovier, B Althaus, R Glueck, et al.
Revue Medicale Suisse|June 16, 2010
[Japanese encephalitis: risk for endemic populations and for travellers]C Hatz, S Inoubli, L Loutan, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 17, 2004
Sodium stibogluconate cardiotoxicity and safety of genericsS Rijal, F Chappuis, R Singh, et al.
Pageof 9